Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators.

Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30.

PMID:
24794721
[PubMed - indexed for MEDLINE]
2.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).

Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K, Haas B, Hahn K, Härter G, Hartmann M, Herzmann C, Hutterer J, Jordan AR, Lange C, Mauss S, Meyer-Olson D, Mosthaf F, Oette M, Reuter S, Rieger A, Rosenkranz T, Ruhnke M, Schaaf B, Schwarze S, Stellbrink HJ, Stocker H, Stoehr A, Stoll M, Träder C, Vogel M, Wagner D, Wyen C, Hoffmann C; Deutsche AIDS Gesellschaft; Österreichische AIDS-Gesellschaft.

Infection. 2013 Sep;41 Suppl 2:S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14.

PMID:
24037688
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.

Hofmann A, Stellmann JP, Kasper J, Ufer F, Elias WG, Pauly I, Repenthin J, Rosenkranz T, Weber T, Köpke S, Heesen C; MS Network Hamburg.

Mult Scler. 2013 Jun;19(7):920-5. doi: 10.1177/1352458512461967. Epub 2012 Oct 4.

PMID:
23037548
[PubMed - indexed for MEDLINE]
4.

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1098-107. Erratum in: N Engl J Med. 2012 Dec 13;367(24):2362.

PMID:
22992073
[PubMed - indexed for MEDLINE]
Free Article
5.

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.

Radue EW, O'Connor P, Polman CH, Hohlfeld R, Calabresi P, Selmaj K, Mueller-Lenke N, Agoropoulou C, Holdbrook F, de Vera A, Zhang-Auberson L, Francis G, Burtin P, Kappos L; FTY720 Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) Study Group.

Arch Neurol. 2012 Oct;69(10):1259-69.

PMID:
22751847
[PubMed - indexed for MEDLINE]
6.

Evaluation of model-based versus non-parametric monaural noise-reduction approaches for hearing aids.

Harlander N, Rosenkranz T, Hohmann V.

Int J Audiol. 2012 Aug;51(8):627-39. doi: 10.3109/14992027.2012.684405. Epub 2012 May 30.

PMID:
22642311
[PubMed - indexed for MEDLINE]
7.

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.

Devonshire V, Havrdova E, Radue EW, O'Connor P, Zhang-Auberson L, Agoropoulou C, Häring DA, Francis G, Kappos L; FREEDOMS study group.

Lancet Neurol. 2012 May;11(5):420-8. doi: 10.1016/S1474-4422(12)70056-X. Epub 2012 Apr 10. Erratum in: Lancet Neurol. 2012 Aug;11(8):658.

PMID:
22494956
[PubMed - indexed for MEDLINE]
8.

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J; SOLAR Study Group.

Neurology. 2012 Mar 13;78(11):841. doi: 10.1212/01.wnl.0000413180.13413.ce. No abstract available.

PMID:
22411961
[PubMed - indexed for MEDLINE]
9.

[Giant cell arteritis with motor involvement of the upper trunk].

Klein M, Rosenkranz T, Vierbuchen M, Terborg C.

Nervenarzt. 2011 Dec;82(12):1612-4. doi: 10.1007/s00115-011-3328-1. German. No abstract available.

PMID:
21739272
[PubMed - indexed for MEDLINE]
10.

Native and unfolded states of phosphoglycerate kinase studied by single-molecule FRET.

Rosenkranz T, Schlesinger R, Gabba M, Fitter J.

Chemphyschem. 2011 Feb 25;12(3):704-10. doi: 10.1002/cphc.201000701. Epub 2010 Nov 5.

PMID:
21344599
[PubMed - indexed for MEDLINE]
11.

Structural stability of soybean (Glycine max) α-amylase: properties of the unfolding transition studied with fluorescence and CD spectroscopy.

Kumari A, Rosenkranz T, Fitter J, Kayastha AM.

Protein Pept Lett. 2011 Mar;18(3):253-60.

PMID:
20955173
[PubMed - indexed for MEDLINE]
12.

Large domain fluctuations on 50-ns timescale enable catalytic activity in phosphoglycerate kinase.

Inoue R, Biehl R, Rosenkranz T, Fitter J, Monkenbusch M, Radulescu A, Farago B, Richter D.

Biophys J. 2010 Oct 6;99(7):2309-17. doi: 10.1016/j.bpj.2010.08.017.

PMID:
20923666
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.

Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J.

Mov Disord. 2010 Aug 15;25(11):1748-52. doi: 10.1002/mds.23342.

PMID:
20740570
[PubMed - indexed for MEDLINE]
14.

The effect of calcium binding on the unfolding barrier: A kinetic study on homologous alpha-amylases.

Kumari A, Rosenkranz T, Kayastha AM, Fitter J.

Biophys Chem. 2010 Sep;151(1-2):54-60. doi: 10.1016/j.bpc.2010.05.005. Epub 2010 May 19.

PMID:
20605671
[PubMed - indexed for MEDLINE]
15.

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20.

PMID:
20089952
[PubMed - indexed for MEDLINE]
Free Article
16.

[Aggressive immunotherapy in Susac's syndrome].

Klein M, Illies T, Georgi S, Rosenkranz T, Terborg C.

Nervenarzt. 2009 Dec;80(12):1502-5. doi: 10.1007/s00115-009-2866-2. German.

PMID:
19888559
[PubMed - indexed for MEDLINE]
17.

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.

O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung HP, Jeffery D, Kappos L, Boateng F, Filippov V, Groth M, Knappertz V, Kraus C, Sandbrink R, Pohl C, Bogumil T; BEYOND Study Group, O'Connor P, Filippi M, Arnason B, Cook S, Goodin D, Hartung HP, Kappos L, Jeffery D, Comi G.

Lancet Neurol. 2009 Oct;8(10):889-97. doi: 10.1016/S1474-4422(09)70226-1. Epub 2009 Sep 2. Erratum in: Lancet Neurol. 2012 Jan;11(1):27. Cree, B [added]; Harung, H-P [corrected to Hartung, H-P]. Lancet Neurol. 2009 Nov;8(11):981. Lancet Neurol. 2011 Feb;10(2):115.

PMID:
19729344
[PubMed - indexed for MEDLINE]
18.

Uneven twins: comparison of two enantiocomplementary hydroxynitrile lyases with alpha/beta-hydrolase fold.

Guterl JK, Andexer JN, Sehl T, von Langermann J, Frindi-Wosch I, Rosenkranz T, Fitter J, Gruber K, Kragl U, Eggert T, Pohl M.

J Biotechnol. 2009 May 20;141(3-4):166-73. doi: 10.1016/j.jbiotec.2009.03.010. Epub 2009 Mar 27.

PMID:
19433222
[PubMed - indexed for MEDLINE]
19.

Observing proteins as single molecules encapsulated in surface-tethered polymeric nanocontainers.

Rosenkranz T, Katranidis A, Atta D, Gregor I, Enderlein J, Grzelakowski M, Rigler P, Meier W, Fitter J.

Chembiochem. 2009 Mar 2;10(4):702-9. doi: 10.1002/cbic.200800739.

PMID:
19191249
[PubMed - indexed for MEDLINE]
20.

Severe Tangier disease with a novel ABCA1 gene mutation.

Schippling S, Orth M, Beisiegel U, Rosenkranz T, Vogel P, Münchau A, Hagel C, Seedorf U.

Neurology. 2008 Oct 28;71(18):1454-5. doi: 10.1212/01.wnl.0000327870.29639.20. No abstract available.

PMID:
18955690
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk